These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 7983392

  • 21. Localized and persistent erythema nodosum leprosum - a rare variant?
    Prabhu S, Rao R, Sripathi H, Rao L, Singh R.
    Dermatol Online J; 2008 Mar 15; 14(3):16. PubMed ID: 18627717
    [Abstract] [Full Text] [Related]

  • 22. Thalidomide levels in patients with erythema nodosum leprosum.
    Vieira JL, Valente Mdo S.
    Ther Drug Monit; 2009 Oct 15; 31(5):602-3. PubMed ID: 19704404
    [Abstract] [Full Text] [Related]

  • 23. Deep vein thrombosis: a rare complication of thalidomide therapy in recurrent erythema nodosum leprosum.
    Sharma NL, Sharma V, Shanker V, Mahajan VK, Sarin S.
    Int J Lepr Other Mycobact Dis; 2004 Dec 15; 72(4):483-5. PubMed ID: 15755204
    [Abstract] [Full Text] [Related]

  • 24. Thalidomide's effectiveness in erythema nodosum leprosum is associated with a decrease in CD4+ cells in the peripheral blood.
    Shannon EJ, Ejigu M, Haile-Mariam HS, Berhan TY, Tasesse G.
    Lepr Rev; 1992 Mar 15; 63(1):5-11. PubMed ID: 1569817
    [Abstract] [Full Text] [Related]

  • 25. Erythema nodosum leprosum necroticans in a child--an unusual manifestation.
    Pandhi D, Mehta S, Agrawal S, Singal A.
    Int J Lepr Other Mycobact Dis; 2005 Jun 15; 73(2):122-6. PubMed ID: 16830655
    [Abstract] [Full Text] [Related]

  • 26. ConA-induced suppressor cells in lepromatous leprosy patients during and after erythema nodosum leprosum.
    Sasiain MC, Ruibal Ares B, Baliña LM, Valdez R, Bachmann AE.
    Int J Lepr Other Mycobact Dis; 1983 Sep 15; 51(3):321-7. PubMed ID: 6227570
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Severe refractory erythema nodosum leprosum successfully treated with the tumor necrosis factor inhibitor etanercept.
    Ramien ML, Wong A, Keystone JS.
    Clin Infect Dis; 2011 Mar 01; 52(5):e133-5. PubMed ID: 21292656
    [Abstract] [Full Text] [Related]

  • 29. The role of thalidomide in the management of erythema nodosum leprosum.
    Walker SL, Waters MF, Lockwood DN.
    Lepr Rev; 2007 Sep 01; 78(3):197-215. PubMed ID: 18035771
    [Abstract] [Full Text] [Related]

  • 30. Thalidomide in erythema nodosum leprosum (ENL).
    Bourdillon C.
    Lepr Rev; 1988 Jun 01; 59(2):184-5. PubMed ID: 3246930
    [No Abstract] [Full Text] [Related]

  • 31. The effects of prednisolone treatment on serological responses and lipid profiles in Ethiopian leprosy patients with Erythema Nodosum Leprosum reactions.
    Negera E, Tilahun M, Bobosha K, Lambert SM, Walker SL, Spencer JS, Aseffa A, Dockrell HM, Lockwood DN.
    PLoS Negl Trop Dis; 2018 Dec 01; 12(12):e0007035. PubMed ID: 30592714
    [Abstract] [Full Text] [Related]

  • 32. Pulse dexamethasone, oral steroids and azathioprine in the management of erythema nodosum leprosum.
    Mahajan VK, Sharma NL, Sharma RC, Sharma A.
    Lepr Rev; 2003 Jun 01; 74(2):171-4. PubMed ID: 12862259
    [No Abstract] [Full Text] [Related]

  • 33. Unexplained delayed nerve impairment in leprosy after treatment.
    Rosenberg NR, Faber WR, Vermeulen M.
    Lepr Rev; 2003 Dec 01; 74(4):357-65. PubMed ID: 14750581
    [Abstract] [Full Text] [Related]

  • 34. Erythema nodosum leprosum and HIV infection: A therapeutic experience.
    Sharma NL, Mahajan VK, Sharma VC, Sarin S, Sharma RC.
    Int J Lepr Other Mycobact Dis; 2005 Sep 01; 73(3):189-93. PubMed ID: 16830640
    [Abstract] [Full Text] [Related]

  • 35. Necrotic erythema nodosum leprosum with oral mucosal involvement.
    Swain JP, Soud A, Agarwal SK.
    Indian J Lepr; 2008 Sep 01; 80(2):175-8. PubMed ID: 19425513
    [Abstract] [Full Text] [Related]

  • 36. Erythema Nodosum Leprosum: Update and challenges on the treatment of a neglected condition.
    Costa PDSS, Fraga LR, Kowalski TW, Daxbacher ELR, Schuler-Faccini L, Vianna FSL.
    Acta Trop; 2018 Jul 01; 183():134-141. PubMed ID: 29474830
    [Abstract] [Full Text] [Related]

  • 37. A randomized, double-blind, double-dummy, controlled dose comparison of thalidomide for treatment of erythema nodosum leprosum.
    Villahermosa LG, Fajardo TT, Abalos RM, Balagon MV, Tan EV, Cellona RV, Palmer JP, Wittes J, Thomas SD, Kook KA, Walsh GP, Walsh DS.
    Am J Trop Med Hyg; 2005 May 01; 72(5):518-26. PubMed ID: 15891124
    [Abstract] [Full Text] [Related]

  • 38. [Review: update on erythema nodosum leprosum].
    Morand JJ, Badiane C, Bobin P.
    Med Trop (Mars); 2004 May 01; 64(5):423-30. PubMed ID: 15771008
    [Abstract] [Full Text] [Related]

  • 39. Increased chitotriosidase activity in serum of leprosy patients: association with bacillary leprosy.
    Iyer A, van Eijk M, Silva E, Hatta M, Faber W, Aerts JM, Das PK.
    Clin Immunol; 2009 Jun 01; 131(3):501-9. PubMed ID: 19307157
    [Abstract] [Full Text] [Related]

  • 40. Leukemoid reaction in erythema nodosum leprosum in a leprosy patient.
    Chaudhary SD, Sen R, Jain VK, Dixit VB.
    Indian J Lepr; 1988 Oct 01; 60(4):572-6. PubMed ID: 3253336
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.